AViTA Corporation (4735) - Total Assets
Based on the latest financial reports, AViTA Corporation (4735) holds total assets worth NT$1.35 Billion TWD (≈ $42.68 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore AViTA Corporation cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
AViTA Corporation - Total Assets Trend (2017–2025)
This chart illustrates how AViTA Corporation's total assets have evolved over time, based on quarterly financial data. See shareholders equity of AViTA Corporation for net asset value and shareholders' equity analysis.
AViTA Corporation - Asset Composition Analysis
Current Asset Composition (December 2025)
AViTA Corporation's total assets of NT$1.35 Billion consist of 49.9% current assets and 50.1% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 19.7% |
| Accounts Receivable | NT$77.72 Million | 5.7% |
| Inventory | NT$88.25 Million | 6.5% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how AViTA Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of AViTA Corporation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: AViTA Corporation's current assets represent 49.9% of total assets in 2025, a decrease from 63.4% in 2017.
- Cash Position: Cash and equivalents constituted 19.7% of total assets in 2025, up from 16.8% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is inventory at 6.5% of total assets.
AViTA Corporation Competitors by Total Assets
Key competitors of AViTA Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Stratec SE
XETRA:SBS
|
Germany | €443.38 Million |
|
T&R Biofab Co. Ltd
KQ:246710
|
Korea | ₩83.86 Billion |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
Novacyt
PA:ALNOV
|
France | €40.28 Million |
|
HeraMED Limited
F:1I4
|
Germany | €1.49 Million |
|
Implanet SA
PA:ALIMP
|
France | €18.45 Million |
AViTA Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.90 | 2.05 | 1.43 |
| Quick Ratio | 1.65 | 1.77 | 1.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$319.82 Million | NT$367.92 Million | NT$580.82 Million |
AViTA Corporation - Advanced Valuation Insights
This section examines the relationship between AViTA Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.19 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 13.7% |
| Total Assets | NT$1.35 Billion |
| Market Capitalization | $37.00 Million USD |
Valuation Analysis
Below Book Valuation: The market values AViTA Corporation's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: AViTA Corporation's assets grew by 13.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for AViTA Corporation (2017–2025)
The table below shows the annual total assets of AViTA Corporation from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | NT$1.35 Billion ≈ $42.68 Million |
+13.74% |
| 2024-12-31 | NT$1.19 Billion ≈ $37.52 Million |
-3.88% |
| 2023-12-31 | NT$1.24 Billion ≈ $39.04 Million |
-7.38% |
| 2022-12-31 | NT$1.34 Billion ≈ $42.15 Million |
-21.06% |
| 2021-12-31 | NT$1.69 Billion ≈ $53.40 Million |
-33.09% |
| 2020-12-31 | NT$2.53 Billion ≈ $79.80 Million |
+143.27% |
| 2019-12-31 | NT$1.04 Billion ≈ $32.80 Million |
-3.50% |
| 2018-12-31 | NT$1.08 Billion ≈ $33.99 Million |
+9.85% |
| 2017-12-31 | NT$982.28 Million ≈ $30.95 Million |
-- |
About AViTA Corporation
AViTA Corporation engages in the research, development, manufacturing, and sales of home healthcare products. Its products include non-contact thermometer, infrared ear/forehead thermometer, infrared ear thermometer, wrist type blood pressure monitor, arm type blood pressure monitor, nasal aspirator, nebulizer, electronic breast pump, pulse oximeter, and electronic lice comb. AViTA Corporation wa… Read more